George Budwell
George Budwell, PhD, is a contributing Motley Fool biotechnology and technology analyst covering disruptive innovators in healthcare, defense, and artificial intelligence. He also writes on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer and a consultant for several life sciences hedge funds. Earlier in his career, he was an evolutionary biologist and completed postdoctoral fellowships at Kyoto University and Illinois State University. He holds a doctorate in evolutionary biology from Tulane University and a bachelor’s degree from Loyola University.
Recent Articles by George Budwell

3 Growth Stocks I'm Loading Up On

3 Robotics Stocks to Buy Hand Over Fist

7 Space Stocks I'd Buy Without Hesitation

5 AI Stocks Every Investor Should Own

Is Oscar Health Stock Still a Buy?

Better Core AI Stock: Nvidia or Palantir Technologies?

Better Growth Stock: Rocket Lab USA vs. Datadog

3 No-Brainer AI Stocks to Buy Right Now

Is Rigetti Computing Stock a Buy?

Is IonQ Stock a Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.